LTZ Therapeutics
PrivateLast Round
Series B
May 6, 2026
Total Funding Raised
$115M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
LTZ Therapeutics is a biotechnology company that develops innovative immunotherapies for cancer and autoimmune diseases using its proprietary Myeloid Engager Platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LTZ Therapeutics Comparables
Compare LTZ Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CREATE Medicines | 81% | |
| Elpiscience Biopharmaceuticals | 79% | |
| Bolt Biotherapeutics | 78% | |
LTZ Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 6, 2026 | ||||
| Series A Extension | Apr 24, 2025 | ||||
| Series A | Jul 30, 2024 | ||||
| VC Round | May 31, 2023 | ||||
| Seed | Apr 7, 2022 |
LTZ Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lanchi Ventures | Series B, Series A Extension |
| Boyu Capital | Series B, Series A Extension |
| Zoo Capital | Series A Extension |
| Hillhouse Investment | Series A, Series A Extension, Series B |
| Lapam Capital | Series A Extension, Series A |
| China Investment Corporation | Series B |
| Unicorn Capital Partners | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 138% MoM, reaching 2.7K.
- May 6, 2026
Raised $38M led by GL Ventures
LTZ Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about LTZ Therapeutics's valuation, stock price, and market status.